CURE - Oncology & Cancer News for Patients & Caregivers
WEBMy Brain Cancer Journey After Giving Birth. October 3o 2024. Path to Previvor: My Journey from Diagnosis to Advocacy. September 28o 2024. My Daughter Talked Through Her Eyes During Cancer. September 21o 2024. CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of the cancer ...
Long-Term Follow-Up Shows Keytruda Continues to Improve
WEBFeb 1, 2021 · Keytruda (pembrolizumab) continued to demonstrate a clinically meaningful improvement in overall and progression-free survival, compared with docetaxel, in patients with previously treated, PD-L1–positive advanced non-small cell lung cancer (NSCLC) after more than five years of follow-up, according to results from the phase 2/3 KEYNOTE-010 study presented at the 2020 World Conference on Lung ...
GO2 For Lung Cancer | Advocacy Groups - Curetoday
WEBGO2 is at the forefront of everything that’s happening in lung cancer. We’re the go-to for one-on-one assistance, supportive connections, screening and treatment information, and finding the best care close to home. We’re the place to go to learn about the latest research and special initiatives that increase survivorship. We’re the source for improving health policies and leading ...
Keytruda Has Received Nearly 40 FDA Approvals. How Does It Work?
WEBJan 25, 2024 · An expert explains how immunotherapy works. The Food and Drug Administration (FDA) recently approved Keytruda (pembrolizumab) plus chemoradiotherapy (CRT) for the treatment of patients with stages 3 to 4A cervical cancer. The first approval of an anti-programmed death receptor-1 (PD-1) therapy in combination with chemoradiotherapy for this ...
ARPIs May Improve Survival in Some With Prostate Cancer
WEBAug 22, 2024 · In patients with metastatic castration-resistant prostate cancer, researchers have found that androgen receptor pathway inhibitors (ARPIs) outperformed the standard of care, which improved responses to treatment and overall survival (OS; time a patient lives, regardless of disease status). Castration-resistant prostate cancer refers to the ...
Heal - Curetoday
WEBCURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of the cancer experience.
Pluvicto Improves Survival Without Progression in Certain Patients …
WEBOct 23, 2023 · Pluvicto improved progression-free survival in certain patients with prostate cancer, recent research showed. Treatment with Pluvicto (177-Lu-PSMA-617) improved the duration of time when a patient’s disease did not progress with a favorable safety profile in patients with metastatic castration-resistant prostate cancer (mCRPC) who were taxane ...
How I Used Turkey Tail Mushrooms Alongside Cancer Treatment
WEBJan 8, 2024 · Turkey tail is a shelf mushroom, named that because of the way they grow on dead and decaying trees like little rows of shelves. Because of its positive effects on the immune system. Studies, such as one published in 2023 in the journal, Cureus, show that use of the mushroom improved outcomes among patients who use it …
Calquence Remains Effective and Safe After 3 Years Compared …
WEBDec 14, 2021 · Calquence, a next-generation BTK inhibitor, significantly prolonged survival compared with standard of care, along with no new side effects at three years in chronic lymphocytic leukemia. These findings also pertained to some patients with …
‘Life Is Never the Same Again’: Cancer Survivors Describe the Most ...
WEBJan 26, 2022 · From mental impacts such as “scanxiety” and post-traumatic stress disorder to difficulties returning to work/dating and long-term physical side effects like memory issues, several cancer survivors shared the hardest part about survivorship.